Routine glaucoma screening program may benefit middle-age African-American patients

Implementing a routine national glaucoma screening program for middle-age African American patients may be clinically effective; however its potential effect on reducing visual impairment and blindness may be modest, according to a computer-based mathematical model reported in the March issue of Archives of Ophthalmology.

"Primary open-angle is a chronic, degenerative disease that affects more than 2.2 million Americans and 1.9 percent of Americans older than 40 years," the authors write as background in the study. "The high prevalence of undiagnosed glaucoma contributes to visual loss, an outcome that is disproportionately common in African American individuals, where as many as 11 percent of elderly patients develop blindness."

Using data from the Eye Diseases Prevalence Research Group and Baltimore Eye Study, Joseph A. Ladapo, M.D., Ph.D., then of Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, now with NYU Langone Medical Center, New York, and colleagues developed a microsimulation computer-based model to project visual outcomes among African American individuals screened for glaucoma under a national .

Based on the developed , the authors found that a universal, community-based glaucoma screening program for African American patients is potentially clinically effective; however, its overall potential effect on visual impairment and blindness appears relatively modest. The authors predict that a glaucoma for between the ages of 50 and 59 years without known glaucoma would reduce the lifetime prevalence of undiagnosed glaucoma from 50 percent to 27 percent, the prevalence of glaucoma-related visual impairment from 4.6 percent to 4.4 percent, and would reduce the prevalence of glaucoma-related blindness from 6.1 percent to 5.6 percent.

The projected cost as outlined by the authors would be $80 per individual screened, considering only the cost of frequency-doubling technology and eye examinations to confirm the diagnosis. The number of patients needed to screen to diagnose one person with glaucoma was estimated at 58, and the number needed to screen to prevent one person from developing visual impairment was estimated at 875. The authors also note that they did not consider "the cost of visual rehabilitation, disability or long-term care in patients with blindness, which are substantial."

"We conclude that routine screening for glaucoma in African American individuals is a potentially clinically effective and economical method to reduce the burden of glaucoma-related visual impairment and blindness, though its absolute benefit is likely to be modest," the authors write. "Future studies should also consider long-term costs associated with treatment and the impact of delaying on health-related quality of life."

More information: Arch Ophthalmol. 2012;130[3]:365-372.

Related Stories

Vision loss more common in people with diabetes

date Oct 13, 2008

Visual impairment appears to be more common in people with diabetes than in those without the disease, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

Recommended for you

Closing the Australian eye health gap may be in sight

date Jun 30, 2015

Three years after the launch of the roadmap to close the gap for vision, progress has been made but "much remains to be done", according to the authors of a Perspective published online today by the Medical Jo ...

Pioneering gene therapy takes aim at inherited blindness

date Jun 29, 2015

Canada's first human gene therapy trial for eyes—the replacement of a faulty gene with a healthy one—is now underway at the Royal Alexandra Hospital to preserve and potentially restore vision for people ...

Iris research focuses on blood vessel patterns

date Jun 29, 2015

The structure of the microvasculature or blood vessels in the iris could play an important role in people's contraction of eye maladies like glaucoma and cataract, according to a WA-led study.

New nanotechnology drug to control blindness

date Jun 25, 2015

The Mexican company "Medical and Surgical Center for Retina" has created a way to deliver drugs in order to avoid risks and painful treatments in people with secondary blindness due to chronic degenerative ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.